会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • METHOD FOR THE PRODUCTION OF RECOMBINANT POLYOMAVIRAL VECTOR PARTICLES
    • 生产重组多核载体载体颗粒的方法
    • EP2421982A1
    • 2012-02-29
    • EP10716326.3
    • 2010-04-22
    • Amarna Holding B.V.
    • VRIES, DE, Walter Gerhardus
    • C12N15/86
    • C12N7/00C12N2710/22051C12N2710/22052
    • The present invention relates to improved methods for the production of viral particles, viral vector particles and recombinant proteins. In particular, the invention relates to improved methods for the production of recombinant polyomaviral vector particles and polyomaviral vector production cell lines. More in particular, the invention relates to methods for the production of simian polyomaviral vector particles such as simian virus 40 (SV40) viral vector particles. The invention also relates to compositions comprising viral vectors and uses thereof and viral vector particles to treat genetic disorders, transplant rejection, autoimmune diseases, infectious diseases, allergies or cancer. The invention also relates to methods for the production of recombinant proteins in mammalian cells and methods to enhance the production of recombinant proteins in mammalian cells.
    • 本发明涉及用于生产病毒颗粒,病毒载体颗粒和重组蛋白的改进方法。 特别地,本发明涉及用于生产重组多瘤病毒载体颗粒和多瘤病毒载体生产细胞系的改进方法。 更特别地,本发明涉及用于生产猿多瘤病毒载体颗粒如猿病毒40(SV40)病毒载体颗粒的方法。 本发明还涉及包含病毒载体的组合物及其用途和病毒载体颗粒,以治疗遗传疾病,移植排斥反应,自身免疫性疾病,感染性疾病,变态反应或癌症。 本发明还涉及在哺乳动物细胞中生产重组蛋白质的方法和增强哺乳动物细胞中重组蛋白质生产的方法。
    • 9. 发明公开
    • Method for the production of recombinant polymavirus vector particles
    • Verfahren zur Herstellung von rekombinanten Polymavirus-Vektorenteilchen
    • EP2243836A1
    • 2010-10-27
    • EP09158498.7
    • 2009-04-22
    • Amarna Therapeutics B.V.
    • Vries, De, Walter Gerhardus
    • C12N15/86
    • C12N7/00C12N2710/22051C12N2710/22052
    • The present invention relates to improved methods for the production of viral particles, viral vectors and recombinant proteins. In particular, the invention relates to improved methods for the production of recombinant polyomavirus vector particles and polyoma vector production cell lines. More in particular, the invention relates to methods for the production of simian polyoma viral vector particles such as simian virus 40 (SV40) viral vector particles. The invention also relates to compositions comprising viral vectors and uses thereof and viral vector particles to treat genetic disorders, transplant rejection, autoimmune diseases, infectious diseases, allergies or cancer. The invention also relates to methods for the production of recombinant proteins in mammalian cells and methods to enhance the production of recombinant proteins in mammalian cells.
    • 本发明涉及用于生产病毒颗粒,病毒载体和重组蛋白质的改进方法。 特别地,本发明涉及用于生产重组多瘤病毒载体颗粒和多瘤病毒载体生产细胞系的改进方法。 更具体地,本发明涉及用于生产猿猴多病毒病毒载体颗粒如猿猴病毒40(SV40)病毒载体颗粒的方法。 本发明还涉及包含病毒载体及其用途的组合物和用于治疗遗传疾病,移植排斥,自身免疫疾病,感染性疾病,过敏或癌症的病毒载体颗粒。 本发明还涉及用于在哺乳动物细胞中产生重组蛋白的方法以及增强哺乳动物细胞中重组蛋白产生的方法。